Ignite Creation Date:
2025-12-17 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 12:38 AM
Study NCT ID:
NCT00750451
Status:
COMPLETED
Last Update Posted:
2009-03-20
First Post:
2008-09-09
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Low Molecular Weight Heparin in Recurrent Implantation Failure
Sponsor:
V.K.V. American Hospital, Istanbul
Organization:
Study Overview
Official Title:
Empirical Low Molecular Weight Heparin Administration in the Luteal Phase in Patients With Recurrent Implantation Failures: a Randomized Open Labeled Trial
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recurrent implantation failure is the failure to achieve a pregnancy after multiple attempts with in vitro fertilization treatment. The reason is usually obscure. Many empirical treatments have been offered without substantial evaluation. Heparin is thought to play a role in the embryo implantation process beyond its anticoagulation effects. The proposed study aims to assess the effectiveness and safety of empirical administration of low molecular weight heparin in patients undergoing a new IVF treatment cycle after multiple failed attempts.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: